Vietnam MOH registration 2400838ĐKLH/BYT-HTTB

Drug test, qualitative antibody test for IgG and IgM against HBcAg

VN: Thuốc thử, chất hiệu chuẩn xét nghiệm định tính kháng thể IgG và IgM kháng HBcAg
Vietnam flagVietnam·Risk Class TTBYT Loại D·Elecsys Anti-HBc II·Roche Diagnostics GmbH·Registered Jun 24, 2024
Registration details
Analysis ID
2400838ĐKLH/BYT-HTTB
Submission ID
000.00.04.G18-230823-0016
Product Type
Elecsys Anti-HBc II
Product Code
09014926190
Company information
Manufacturer Country
GERMANY
Authorized Representative
CÔNG TY TNHH ROCHE VIỆT NAM
Technical details
Intended Use
In vitro immunoassay for the qualitative determination of IgG and IgM antibodies against the core antigen of the hepatitis B virus in human serum and plasma. The "ECLIA" (electrochemiluminescence immunoassay "ECLIA") is used for the cobas e immunoassay analyzers.
Dates and status
Registration Date
Jun 24, 2024
Companies making similar products

Companies providing products similar to "Drug test, qualitative antibody test for IgG and IgM against HBcAg"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Drug test, qualitative antibody test for IgG and IgM against HBcAg in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2400838ĐKLH/BYT-HTTB and manufactured by Roche Diagnostics GmbH. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo phụ lục, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI300,000+ Devices1 Competitors1 Recent Registrations